Seek truth from facts, competitive symbiosis
01
2022-01
On January 10, Zou Xingwang, Vice Mayor of the Municipal People's Government, and his delegation visited Zhengqing for inspection, accompanied by Zhang Xisong, Secretary of the Huaihua High-tech Zone Party Working Committee. She Weijia, Chairman of the Group Company's Board of Supervisors and Chairman of the Labor Union, received Zou Xingwang and his delegation.
01
2022-01
On the afternoon of January 2, the First Session of the Sixth Huaihua Municipal People's Congress successfully concluded after completing all items on its agenda. During the meeting, Long Xianjun, a deputy to the Municipal People's Congress and the rotating president of Zhengqing Group, attended the meeting, actively fulfilling his rights and obligations as a deputy, and submitted the "Proposal on Accelerating the Construction of Huaihua City's Comprehensive Reform Pilot Zone for Traditional Chinese Medicine". After the meeting, Deputy Long Xianjun returned to his work post with a refreshed spirit and great expectations for the future development of the enterprise, full of confidence.
01
2022-01
On December 16, the Hunan Province 'Two New' Fields 'Benchmark Party Organization' Award Ceremony was held in Changsha High-tech Zone. The meeting announced the document 'Xiang Liang Xin Fa [2021] No. 9', which identified 99 primary-level Party organizations in the 'Two New' fields as provincial 'Benchmark Party Organizations' in the 'Two New' fields. The CPC Committee of Hunan Zhengqing Pharmaceutical Group Co., Ltd. was designated as a 'Benchmark Party Organization' in Hunan Province's 'Two New' fields. A total of five Party organizations in Huaihua City were on the confirmed list, and the CPC Zhengqing Group Committee was the only enterprise Party organization selected from Huaihua High-tech Zone. This is another honor following the CPC Zhengqing Group Committee being awarded the honorary title of 'Advanced Primary-level Party Organization' by the Provincial Party Committee's 'Two New' Work Committee.
06
2021-06
Hunan Zhengqing Pharmaceutical Group Co., Ltd. Announcement of Resolutions from the 2020 Annual General Meeting of Shareholders I. Meeting Convening and Attendance Time: June 18, 2021, 9:30 AM Venue: 5th Floor Meeting Room, No. 7 Cai Fu Road, Huaihua High-tech Development Zone, Hunan Method: On-site Convenor: Board of Directors Chairperson: Chairman Wu Feichi A total of 18 shareholders and shareholder representatives attended this general meeting, holding 180,818,025 shares with voting rights, accounting for 88.5191% of the company's total shares. II. Review of Proposals A total of 20 proposals were reviewed at this meeting, all approved with 100% of the voting shares held by the attending shareholders. Specifically: 1. "Company's 2020 Annual Board of Directors' Work Report"; 2. "Company's 2020 Annual Board of Supervisors' Work Report"; 3. "Company's 2020 Annual Audit Report"; 4. "Company's 2020 Annual Financial Settlement and 2021 Annual Financial Budget Report"; 5. "Company's 2020 Annual Profit Distribution Plan"; 6. "Proposal on Appointing the Accounting Firm for 2021"; 7. "Proposal on Confirming the Company's 2020 Daily Related Party Transactions and Estimating 2021 Daily Related Party Transactions" (Related parties Huaihua Dadi Holding Co., Ltd., Hunan Xiangjiang Liyuan Zhenghong Venture Capital Partnership (Limited Partnership), Huaihua High-tech Industrial Investment Partnership (Limited Partnership), Huaihua Mountain Operations Co., Ltd., Wu Feichi, and Huang Yuming abstained from voting on this proposal); 8. "Proposal on Amending the
05
2021-05
Notice of the 2020 Annual General Meeting of Shareholders
Hunan Zhengqing Pharmaceutical Group Co., Ltd.Resolution of the 12th Meeting of the 6th Board of Directorsand Notice of Convening the 2020 Annual Shareholders' MeetingHunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held the 12th Meeting of the 6th Board of Directors on May 27, 2021, at Zhengqing Group, No. 7 Cailu Road, High-tech Zone, Huaihua, Hunan. The meeting notice was delivered to all directors on May 17, 2021, by phone, fax, and other means. Five directors of the Company should have attended the meeting; five directors actually attended and voted. The meeting was chaired by Mr. Wu Feichi, Chairman. The meeting approved proposals such as the "Company's 2020 Annual Board of Directors' Work Report" by vote and submitted them to the Shareholders' Meeting for deliberation.The relevant matters for the Company's 2020 Annual Shareholders' Meeting are hereby notified as follows:1. Meeting Time: 9:30 AM, June 18, 20212. Meeting Venue: Zhengqing Group, No. 7 Cailu Road, High-tech Zone, Huaihua, Hunan3. Convener of the Meeting: The Company's Board of Directors4. Attendees:(1) Directors, Supervisors, and Senior Management of the Company;(2) Shareholders registered as of June 13, 2021;(3) Lawyers hired by the Company and other personnel invited by the Company's Board of Directors.I. Matters for Deliberation at the MeetingThis meeting will deliberate on the following proposals:1. "Company's 2020 Annual Board of Directors' Work Report";2. "Company's 2020 Annual Supervisors' Work Report";3. "Company's 2020 Annual Audit Report";4. "Company's 2020 Annual Financial Final Accounts and 2021 Annual Financial Budget Report";5. "Company's 2020 Annual Profit Distribution Plan";6. "Proposal on Engaging an Accounting Firm for 2021";7. "Proposal on Confirming the Company's 2020 Annual Related Party Transactions and Estimating 2021 Annual Related Party Transactions";8. "Proposal on Amending the
04
2021-04
The board of directors and all directors of the company guarantee that there are no false records, misleading statements, or major omissions in the content of this announcement, and they assume legal responsibility for the truthfulness, accuracy, and completeness of its content.Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as “the Company”) has obtained approval from the China Securities Regulatory Commission for its targeted issuance of shares to specific investors (hereinafter referred to as “this targeted issuance”) through the “Approval on the Targeted Issuance of Shares by Hunan Zhengqing Pharmaceutical Group Co., Ltd.” (CSRC Approval [2020] No. 2165), approving the company to issue no more than 134,000,000 new shares in a targeted manner.The Company completed this targeted issuance in April 2021, issuing a total of 134,000,000 RMB ordinary shares to 6 specific investors at an issuance price of RMB 3.5 per share, raising a total of RMB 469,000,000, of which RMB 134,000,000 is newly added registered capital (share capital).According to the results of this targeted issuance and the authorization of the company's general meeting of shareholders, the company has amended relevant clauses in its “Articles of Association.” Article 4 of Chapter 1 has been revised to “The company's registered capital is RMB 204,270,346”; Article 16 of Chapter 3 has been revised to “The company's total shares are 204,270,346 shares.” The company has now completed the industrial and commercial registration procedures for the amendment of its “Articles of Association” and the change in registered capital, and has obtained a new “Business License.” This targeted issuance has been completed according to legal procedures.The company will subsequently handle the registration and custody procedures at Hunan Equity Registration and Management Center Co., Ltd.This announcement is hereby made.Hunan Zhengqing Pharmaceutical Group Co., Ltd.Board of DirectorsApril 23, 2021
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地